Charles River Laboratories

Chiltern, Charles River Labs Partner on Early-phase Studies

Friday, February 26, 2010 06:54 AM

UK contract research organization (CRO) Chiltern International and preclinical CRO Charles River Laboratories are partnering to conduct and support early-phase radiolabelled studies.

More... »

Charles River Labs Halts Preclinical Operations at MA Facility

Wednesday, January 13, 2010 07:20 AM

In response to decreased demand for preclinical services, Charles River Laboratories is halting operations at its Shrewsbury, Mass., preclinical services facility by the middle of 2010, once on-going studies are completed. The contract research organization (CRO) said it plans to resume operations when the global preclinical market improves.

More... »

Charles River's Shanghai Facility Receives Accreditation

Thursday, October 15, 2009 07:44 AM

Preclinical CRO Charles River Laboratories’ Shanghai facility received accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC), the Canadian Council on Animal Care (CCAC) and the Shanghai Laboratory Animal Commission (SLAC).

More... »

Charles River Labs Lowers Guidance, Acquires Two Companies

Friday, August 7, 2009 11:47 AM

At the same timeCharles River Laboratories announced the acquisition of two companies, the preclinical contract research organization (CRO) lowered its full-year guidance for 2009.

More... »

Quotient Bioresearch Acquires Edinburgh Facility

Tuesday, May 26, 2009 08:00 AM

U.K.-based Quotient Bioresearch acquired an Edinburgh clinical research facility to supplement the company’s growing clinical research business.

More... »

PPD Acquires Magen BioSciences, Plans to Sell Piedmont Research

Friday, April 3, 2009 02:00 PM

PPD acquired Magen BioSciences, a dermatology-focused biotechnology company—just as the contract research organization (CRO) announced plans to divest its preclinical research subsidiary Piedmont Research Center.

More... »

Charles River to Cut Headcount by 3% Due to Slow Q4

Wednesday, February 11, 2009 07:00 AM

Wilmington, Mass.-based Charles River Laboratories reported another quarter of slower than expected sales growth in its Preclinical Services Segment (PCS), prompting the company to announce cost-saving measures including a 3% reduction in headcount for the first quarter 2009.

More... »

Charles River’s Preclinical Growth Slows, Lowers Guidance

Thursday, November 6, 2008 10:48 AM

Wilmington, Mass.-based Charles River Laboratories saw slower than expected sales growth in its Preclinical Services Segment (PCS) during the third quarter, prompting the preclinical contract research organization (CRO) to reduce its 2008 profit and revenue-growth forecasts. Strong sales in Charles River’s Research Models and Services (RMS) segment helped offset the performance of PCS, but the company reduced the high-end of its full-year sales growth percentage forecast by 4%, from 14% to 10%.

More... »

Preclinical CROs Expand Operations to Shanghai

Monday, October 27, 2008 09:36 AM

China has seen significant growth in the area of drug research and development in the past few years, and this growth will continue into the fourth quarter of 2008 with the opening of two new preclinical facilities in Shanghai.

More... »

Charles River Labs to Open Preclinical Facility in Shanghai

Wednesday, October 15, 2008 12:41 PM

Preclinical research powerhouse Charles River Laboratories is expanding its global reach with a new 60,000-square-foot facility in Shanghai, China.

More... »